Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites.

Michonneau D, Latis E, Curis E, Dubouchet L, Ramamoorthy S, Ingram B, de Latour RP, Robin M, de Fontbrune FS, Chevret S, Rogge L, Socié G.

Nat Commun. 2019 Dec 13;10(1):5695. doi: 10.1038/s41467-019-13498-3.

2.

Healthcare providers' perception of the referral system in maternal care facilities in Aceh, Indonesia: a cross-sectional study.

Diba F, Ichsan I, Muhsin M, Marthoenis M, Sofyan H, Andalas M, Monfared I, Richert K, Kaplan L, Rogge L, Doria S, Samadi S, Vollmer S.

BMJ Open. 2019 Dec 8;9(12):e031484. doi: 10.1136/bmjopen-2019-031484.

3.

Author Correction: NFAT primes the human RORC locus for RORγt expression in CD4+T cells.

Yahia-Cherbal H, Rybczynska M, Lovecchio D, Stephen T, Lescale C, Placek K, Larghero J, Rogge L, Bianchi E.

Nat Commun. 2019 Nov 26;10(1):5450. doi: 10.1038/s41467-019-13451-4.

4.

NFAT primes the human RORC locus for RORγt expression in CD4+ T cells.

Yahia-Cherbal H, Rybczynska M, Lovecchio D, Stephen T, Lescale C, Placek K, Larghero J, Rogge L, Bianchi E.

Nat Commun. 2019 Oct 16;10(1):4698. doi: 10.1038/s41467-019-12680-x. Erratum in: Nat Commun. 2019 Nov 26;10(1):5450.

5.

Using peer education to improve diabetes management and outcomes in a low-income setting: a randomized controlled trial.

Seuring T, Marthoenis, Rhode S, Rogge L, Rau H, Besançon S, Zufry H, Sofyan H, Vollmer S.

Trials. 2019 Sep 2;20(1):548. doi: 10.1186/s13063-019-3656-1.

6.

The IL-23/IL-17 pathway in human chronic inflammatory diseases - new insight from genetics and targeted therapies.

Bianchi E, Rogge L.

Microbes Infect. 2019 Jun - Jul;21(5-6):246-253. doi: 10.1016/j.micinf.2019.06.009. Epub 2019 Jun 25.

PMID:
31252215
7.

The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies.

Bianchi E, Rogge L.

Genes Immun. 2019 May;20(5):415-425. doi: 10.1038/s41435-019-0067-y. Epub 2019 Apr 19. Review.

PMID:
31000797
8.

Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Menegatti S, Bianchi E, Rogge L.

Front Immunol. 2019 Mar 19;10:382. doi: 10.3389/fimmu.2019.00382. eCollection 2019. Review.

9.

Expansion of Interleukin-22- and Granulocyte-Macrophage Colony-Stimulating Factor-Expressing, but Not Interleukin-17A-Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis.

Blijdorp ICJ, Menegatti S, van Mens LJJ, van de Sande MGH, Chen S, Hreggvidsdottir HS, Noordenbos T, Latuhihin TE, Bernink JH, Spits H, Rogge L, Baeten DLP, Yeremenko NG.

Arthritis Rheumatol. 2019 Mar;71(3):392-402. doi: 10.1002/art.40736. Epub 2019 Jan 15.

10.

Brief Report: Interleukin-17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses.

van Mens LJJ, van de Sande MGH, Menegatti S, Chen S, Blijdorp ICJ, de Jong HM, Fluri IA, Latuhihin TE, van Kuijk AWR, Rogge L, Yeremenko NG, Baeten DLP.

Arthritis Rheumatol. 2018 Dec;70(12):1994-2002. doi: 10.1002/art.40581. Epub 2018 Oct 17.

11.

Publisher Correction: Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.

Patin E, Hasan M, Bergstedt J, Rouilly V, Libri V, Urrutia A, Alanio C, Scepanovic P, Hammer C, Jönsson F, Beitz B, Quach H, Lim YW, Hunkapiller J, Zepeda M, Green C, Piasecka B, Leloup C, Rogge L, Huetz F, Peguillet I, Lantz O, Fontes M, Di Santo JP, Thomas S, Fellay J, Duffy D, Quintana-Murci L, Albert ML; Milieu Intérieur Consortium.

Nat Immunol. 2018 Jun;19(6):645. doi: 10.1038/s41590-018-0105-3.

PMID:
29725081
12.

Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.

Patin E, Hasan M, Bergstedt J, Rouilly V, Libri V, Urrutia A, Alanio C, Scepanovic P, Hammer C, Jönsson F, Beitz B, Quach H, Lim YW, Hunkapiller J, Zepeda M, Green C, Piasecka B, Leloup C, Rogge L, Huetz F, Peguillet I, Lantz O, Fontes M, Di Santo JP, Thomas S, Fellay J, Duffy D, Quintana-Murci L, Albert ML; Milieu Intérieur Consortium.

Nat Immunol. 2018 Mar;19(3):302-314. doi: 10.1038/s41590-018-0049-7. Epub 2018 Feb 23. Erratum in: Nat Immunol. 2018 May 3;:.

PMID:
29476184
13.

Regulatory T cells control toxicity in a humanized model of IL-2 therapy.

Li Y, Strick-Marchand H, Lim AI, Ren J, Masse-Ranson G, Dan Li, Jouvion G, Rogge L, Lucas S, Bin Li, Di Santo JP.

Nat Commun. 2017 Nov 24;8(1):1762. doi: 10.1038/s41467-017-01570-9.

14.

Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.

Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Norel X, Sallenave JM, Allez M, Graf T, Hendriks RW, Casanova JL, Amit I, Yssel H, Di Santo JP.

Cell. 2017 Mar 9;168(6):1086-1100.e10. doi: 10.1016/j.cell.2017.02.021.

15.

IL-12 drives functional plasticity of human group 2 innate lymphoid cells.

Lim AI, Menegatti S, Bustamante J, Le Bourhis L, Allez M, Rogge L, Casanova JL, Yssel H, Di Santo JP.

J Exp Med. 2016 Apr 4;213(4):569-83. doi: 10.1084/jem.20151750. Epub 2016 Mar 14.

16.

Automated flow cytometric analysis across large numbers of samples and cell types.

Chen X, Hasan M, Libri V, Urrutia A, Beitz B, Rouilly V, Duffy D, Patin É, Chalmond B, Rogge L, Quintana-Murci L, Albert ML, Schwikowski B; Milieu Intérieur Consortium.

Clin Immunol. 2015 Apr;157(2):249-60. doi: 10.1016/j.clim.2014.12.009. Epub 2015 Jan 7.

17.

Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping.

Hasan M, Beitz B, Rouilly V, Libri V, Urrutia A, Duffy D, Cassard L, Di Santo JP, Mottez E, Quintana-Murci L, Albert ML, Rogge L; Milieu Intérieur Consortium.

Clin Immunol. 2015 Apr;157(2):261-76. doi: 10.1016/j.clim.2014.12.008. Epub 2015 Jan 6.

18.

Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.

Duffy D, Rouilly V, Libri V, Hasan M, Beitz B, David M, Urrutia A, Bisiaux A, Labrie ST, Dubois A, Boneca IG, Delval C, Thomas S, Rogge L, Schmolz M, Quintana-Murci L, Albert ML; Milieu Intérieur Consortium.

Immunity. 2014 Mar 20;40(3):436-50. doi: 10.1016/j.immuni.2014.03.002.

19.

Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.

Dong S, Maiella S, Xhaard A, Pang Y, Wenandy L, Larghero J, Becavin C, Benecke A, Bianchi E, Socié G, Rogge L.

Blood. 2013 Sep 5;122(10):1802-12. doi: 10.1182/blood-2013-02-482539. Epub 2013 Jul 1.

PMID:
23818545
20.

Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis.

Coffre M, Roumier M, Rybczynska M, Sechet E, Law HK, Gossec L, Dougados M, Bianchi E, Rogge L.

Arthritis Rheum. 2013 Jun;65(6):1510-21. doi: 10.1002/art.37936.

21.

Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.

Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE.

Infect Immun. 2012 Mar;80(3):975-81. doi: 10.1128/IAI.05557-11. Epub 2011 Dec 19.

22.

Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells.

Moreira-Teixeira L, Resende M, Coffre M, Devergne O, Herbeuval JP, Hermine O, Schneider E, Rogge L, Ruemmele FM, Dy M, Cordeiro-da-Silva A, Leite-de-Moraes MC.

J Immunol. 2011 May 15;186(10):5758-65. doi: 10.4049/jimmunol.1003043. Epub 2011 Apr 8.

23.

Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the "N4-like viruses".

Ceyssens PJ, Brabban A, Rogge L, Lewis MS, Pickard D, Goulding D, Dougan G, Noben JP, Kropinski A, Kutter E, Lavigne R.

Virology. 2010 Sep 15;405(1):26-30. doi: 10.1016/j.virol.2010.06.011.

24.

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients.

Weiss L, Letimier FA, Carriere M, Maiella S, Donkova-Petrini V, Targat B, Benecke A, Rogge L, Levy Y.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10632-7. doi: 10.1073/pnas.1000027107. Epub 2010 May 24.

25.

The human COP9 signalosome protects ubiquitin-conjugating enzyme 3 (UBC3/Cdc34) from beta-transducin repeat-containing protein (betaTrCP)-mediated degradation.

Fernandez-Sanchez ME, Sechet E, Margottin-Goguet F, Rogge L, Bianchi E.

J Biol Chem. 2010 Jun 4;285(23):17390-7. doi: 10.1074/jbc.M109.076661. Epub 2010 Apr 8.

26.

Integration of distinct intracellular signaling pathways at distal regulatory elements directs T-bet expression in human CD4+ T cells.

Placek K, Gasparian S, Coffre M, Maiella S, Sechet E, Bianchi E, Rogge L.

J Immunol. 2009 Dec 15;183(12):7743-51. doi: 10.4049/jimmunol.0803812.

27.

Genetic and epigenetic networks controlling T helper 1 cell differentiation.

Placek K, Coffre M, Maiella S, Bianchi E, Rogge L.

Immunology. 2009 Jun;127(2):155-62. doi: 10.1111/j.1365-2567.2009.03059.x. Review.

28.

Jakmip1 is expressed upon T cell differentiation and has an inhibitory function in cytotoxic T lymphocytes.

Libri V, Schulte D, van Stijn A, Ragimbeau J, Rogge L, Pellegrini S.

J Immunol. 2008 Nov 1;181(9):5847-56.

29.

Long oligonucleotide microarrays for African green monkey gene expression profile analysis.

Jacquelin B, Mayau V, Brysbaert G, Regnault B, Diop OM, Arenzana-Seisdedos F, Rogge L, Coppée JY, Barré-Sinoussi F, Benecke A, Müller-Trutwin MC.

FASEB J. 2007 Oct;21(12):3262-71. Epub 2007 May 16.

PMID:
17507667
30.
31.

A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.

Vosshenrich CA, García-Ojeda ME, Samson-Villéger SI, Pasqualetto V, Enault L, Richard-Le Goff O, Corcuff E, Guy-Grand D, Rocha B, Cumano A, Rogge L, Ezine S, Di Santo JP.

Nat Immunol. 2006 Nov;7(11):1217-24. Epub 2006 Oct 1. Erratum in: Nat Immunol. 2006 Dec;7(12):1343.

PMID:
17013389
32.

The COP9 signalosome regulates Skp2 levels and proliferation of human cells.

Denti S, Fernandez-Sanchez ME, Rogge L, Bianchi E.

J Biol Chem. 2006 Oct 27;281(43):32188-96. Epub 2006 Aug 30.

33.

RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1.

Denti S, Sirri A, Cheli A, Rogge L, Innamorati G, Putignano S, Fabbri M, Pardi R, Bianchi E.

J Biol Chem. 2004 Mar 26;279(13):13027-34. Epub 2004 Jan 13.

34.

Gene profiling of lymphoma, myeloma, and AML.

Rogge L, Bianchi E.

MedGenMed. 2003 Jul 24;5(3):12. Review. No abstract available.

35.

Dissecting oncogenes and tyrosine kinases in AML cells.

Bianchi E, Rogge L.

MedGenMed. 2003 Jul 21;5(3):10. Review. No abstract available.

36.

Antileukemic activity of natural killer cells in allogeneic BMT.

Bianchi E, Rogge L.

MedGenMed. 2003 Jul 18;5(3):9. Review. No abstract available.

37.

Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritis.

De Benedetti F, Pignatti P, Biffi M, Bono E, Wahid S, Ingegnoli F, Chang SY, Alexander H, Massa M, Pistorio A, Martini A, Pitzalis C, Sinigaglia F, Rogge L.

J Rheumatol. 2003 Jul;30(7):1611-5.

PMID:
12858466
38.

Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.

Kiani A, Habermann I, Schäke K, Neubauer A, Rogge L, Ehninger G.

Haematologica. 2003 Jul;88(7):754-61.

39.

Gene profiling for defining targets for new therapeutics in autoimmune diseases.

Rogge L.

Arthritis Res Ther. 2003;5(2):47-50. Epub 2003 Jan 6. Review.

40.

Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity.

Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R.

J Biol Chem. 2003 May 30;278(22):19682-90. Epub 2003 Mar 3.

41.

A genomic view of helper T cell subsets.

Rogge L.

Ann N Y Acad Sci. 2002 Dec;975:57-67. Review.

PMID:
12538154
42.

Down-modulation of responses to type I IFN upon T cell activation.

Dondi E, Rogge L, Lutfalla G, Uzé G, Pellegrini S.

J Immunol. 2003 Jan 15;170(2):749-56.

43.

Gene expression profiling in immune cells using microarray.

Granucci F, Castagnoli PR, Rogge L, Sinigaglia F.

Int Arch Allergy Immunol. 2001 Dec;126(4):257-66. Review.

PMID:
11815732
44.

Proliferative responses to selected peptides of IA-2 in identical twins discordant for Type 1 diabetes.

Schulz RM, Hawa M, Leslie RD, Sinigaglia F, Passini N, Rogge L, Picard JK, Londei M.

Diabetes Metab Res Rev. 2000 May-Jun;16(3):150-6.

PMID:
10867713
45.

Transcript imaging of the development of human T helper cells using oligonucleotide arrays.

Rogge L, Bianchi E, Biffi M, Bono E, Chang SY, Alexander H, Santini C, Ferrari G, Sinigaglia L, Seiler M, Neeb M, Mous J, Sinigaglia F, Certa U.

Nat Genet. 2000 May;25(1):96-101.

PMID:
10802665
46.

Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.

Bianchi E, Denti S, Granata A, Bossi G, Geginat J, Villa A, Rogge L, Pardi R.

Nature. 2000 Apr 6;404(6778):617-21.

PMID:
10766246
47.

IL-12 receptor regulation in IL-12-deficient BALB/c and C57BL/6 mice.

Galbiati F, Rogge L, Adorini L.

Eur J Immunol. 2000 Jan;30(1):29-37.

48.

Type I interferons and the Th1/Th2 paradigm.

Sinigaglia F, D'Ambrosio D, Rogge L.

Dev Comp Immunol. 1999 Oct-Dec;23(7-8):657-63. Review.

PMID:
10579394
49.

Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function.

Sinigaglia F, D'Ambrosio D, Panina-Bordignon P, Rogge L.

Immunol Rev. 1999 Aug;170:65-72. Review.

PMID:
10566142
50.

Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells.

Colantonio L, Iellem A, Clissi B, Pardi R, Rogge L, Sinigaglia F, D'Ambrosio D.

Blood. 1999 Nov 1;94(9):2981-9.

PMID:
10556180

Supplemental Content

Support Center